Inpharmatica Signs Genentech as Subscriber to Proteomics Platform | GenomeWeb

NEW YORK, March 21 - Inpharmatica said Wednesday that Genentech of South San Francisco, Calif., has acquired a three-year non-exclusive subscription to Inpharmatica's Biopendium proteomic analysis system. 

Under the terms of the multi-million dollar agreement, Inpharmatica of London, UK, will develop a customized version of Biopendium for Genentech by incorporating Genentech's proprietary genome sequence data into the platform. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

In Nature this week: genetic history of HIV in the US, and more.